Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 0.57 |
| ▸ | ELANE | P08246 | 3/20 | 0.52 |
| ▸ | TTR | P02766 | 4/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | USP2 | O75604 | 2/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.45 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.45 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.45 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.45 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8996376 | 0.83 | TTR (0.51) | HTTELANETTRKDM4EMAPT | |
| SCHEMBL5821938 | 0.82 | HTT (0.50) | HTTELANETTRKDM4EMAPT | |
| SCHEMBL22324683 | 0.82 | TTR (0.44) | HTTELANETTRKDM4EMAPT | |
| SCHEMBL22323640 | 0.81 | MAPT (0.44) | HTTELANETTRKDM4EMAPT | |
| SCHEMBL497339 | 0.81 | MAPT (0.60) | HTTTTRKDM4EMAPTTP53 | |
| SCHEMBL29551111 | 0.81 | MAPT (0.60) | HTTTTRKDM4EMAPTTP53 | |
| SCHEMBL22343439 | 0.81 | TTR (0.43) | HTTELANETTRKDM4EMAPT | |
| SCHEMBL26187355 | 0.78 | ELANE (0.69) | HTTELANETTRKDM4EMAPT | |
| SCHEMBL4645309 | 0.76 | SMN1; SMN2 (0.58) | HTTELANETTRKDM4EMAPT | |
| SCHEMBL14507724 | 0.76 | HTT (0.59) | HTTELANEKDM4EMAPTTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220109157-A1 | Conducting redox oligomers | SJOEDIN MARTIN (SE) | 2022-04-07 | — | — | US | disclosed |
| WO-2020162824-A1 | CONDUCTING REDOX OLIGOMERS | SJÖDIN MARTIN (SE) | 2020-08-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220109157-A1 | Conducting redox oligomers | NOX4, CYBB, LPO | HTT 1225/4885ELANE 3112/4885TTR 255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.